Randomized Controlled Trial
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Sep 27, 2022; 14(9): 1037-1048
Published online Sep 27, 2022. doi: 10.4240/wjgs.v14.i9.1037
Table 4 Changes in serum interleukin-6, tumor necrosis factor-α, troponin I, and N-terminal pro-brain natriuretic peptide levels at every time point


IL-6 (pg/mL)
TNF-α (pg/mL)
cTnI (ug/L)
NT-proBNP (ng/L)
Control group (n = 65)T078.9 ± 23.287.5 ± 25.60.032 ± 0.015556.6 ± 251.2
T1170.4 ± 42.3b175.3 ± 43.1b0.383 ± 0.166b1012.4 ± 568.8b
T2126.2 ± 33.6b129.5 ± 35.2b0.182 ± 0.067b866.0 ± 283.6b
T380.7 ± 23.292.8 ± 26.80.030 ± 0.011667.4 ± 247.7
CO-G group (n = 65)T080.6 ± 22.583.2 ± 23.80.029 ± 0.012562.2 ± 195.8
T1145.5 ± 34.5a,b156.7 ± 36.1a,b0.255 ± 0.128a,b876.7 ± 268.2a,b
T2108.6 ± 24.9a,b115.5 ± 25.6a,b0.116 ± 0.070a,b594.0 ± 163.3a,b
T378.6 ± 21.986.2 ± 22.60.028 ± 0.011462.6 ± 154.5a,b